Condition: Spinal Stenosis Lumbar · Disc Degeneration · Disc Disease · Sponsor: Potsawat Surabotsopon
Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.
This description comes directly from the study's public registry record.
Konthorn Chankong, Master's degree · +66859496902 · gearkonthorn@gmail.com
Always discuss trial participation with your own doctor first.
| Thammasat university hospital | Pathum Thani, Changwat Pathum Thani, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06367855